Skip to main content
. 2024 Jul 31;11:1411752. doi: 10.3389/fcvm.2024.1411752

Table 5.

4D measurements of the great vessels and valves in the patient cohort.

Left heart Right heart
4Dprosp 4Dretro p 4Dprosp 4Dretro p
Vessels Ascending aorta Pulmonary artery
 Total volume (ml) 73 ± 13 66 ± 12 0.08 72 ± 10 75 ± 9 0.38
 Cardiac output (L/min) 4.9 ± 0.9 4.5 ± 1.1 0.23 4.9 ± 1.0 5.2 ± 0.8 0.36
 Max flow rate (ml/s) 322 ± 66 287 ± 12 0.04 319 ± 56 330 ± 62 0.65
 Max velocity (cm/s) 75 ± 24 70 ± 25 0.20 78 ± 5 81 ± 21 0.73
 Max pressure gradient (mmHg) 2.5 ± 1.6 2.2 ± 1.4 0.25 2.4 ± 0.3 2.8 ± 1.6 0.63
 Pulse wave velocity (m/s) 9.0 ± 3.8 8.4 ± 2.8 0.69
Semilunar valves Aortic valve Pulmonary valve
 Total volume (ml) 71 ± 11 71 ± 11 0.97 72 ± 11 73 ± 9 0.75
 Cardiac output (L/min) 4.8 ± 1.0 4.9 ± 1.2 0.70 4.9 ± 1.0 5.0 ± 1.0 0.55
 Max pressure gradient (mmHg) 8.2 ± 3.9 6.9 ± 1.6 0.24 3.5 ± 1.4 3.4 ± 1.4 0.66
 Max flow rate (ml/s) 342 ± 66 345 ± 71 0.88 364 ± 64 356 ± 71 0.52
 Max velocity (cm/s) 142 ± 25 130 ± 16 0.22 92 ± 17 91 ± 17 0.68
Atrioventricular valves Mitral valve Tricuspid valve
 Total volume (ml) 51 ± 7 70 ± 11 0.03 45 ± 7 67 ± 12 0.03
 Semilunar-atrioventricular volume mismatch (Δml, [%]) −20 ± 10
[−40 ± 20]
−2 ± 3
[−3 ± 4]
<0.01 −28 ± 14
[−37 ± 17]
−7 ± 8
[−9 ± 10]
0.03
 Max pressure gradient (mmHg) 1.6 ± 0.7 1.6 ± 0.8 0.95 1.1 ± 0.3 1.2 ± 0.8 0.66
Early diastolic (E)
 E-volume (ml) 49 ± 8 45 ± 11 0.22 46 ± 10 42 ± 12 0.27
 E-peak flow rate (ml/s) 345 ± 88 297 ± 77 0.34 258 ± 88 238 ± 56 0.61
 E-peak velocity (cm/s) 63 ± 13 58 ± 16 0.73 44 ± 10 41 ± 8 0.42
Late diastolic (A)
 A-volume (ml) 2 ± 3 27 ± 14 <0.01 2 ± 3 27 ± 14 <0.01
 A-peak flow rate (ml/s) 270 ± 83 270 ± 46
 A-peak velocity (cm/s) 57 ± 11 49 ± 21
 E/A- max flow rate 1.3 ± 0.5 0.9 ± 0.1
 E/A- max velocity 1.2 ± 0.4 0.9 ± 0.2

Mean ± SD are shown for vascular and valvular measurements of patients with cardiovascular disease (n = 6) from both 4D sequences which were prospectively (4Dprosp) and retrospectively gated (4Dretro).